VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 110 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $575,671 | -28.8% | 74,280 | +5.2% | 0.00% | – |
| Q2 2023 | $808,596 | -25.0% | 70,620 | -49.5% | 0.00% | – |
| Q1 2023 | $1,078,228 | +152.8% | 139,848 | +100.0% | 0.00% | – |
| Q4 2022 | $426,469 | +3.0% | 69,913 | +0.0% | 0.00% | – |
| Q3 2022 | $414,000 | 0.0% | 69,902 | -0.1% | 0.00% | – |
| Q2 2022 | $414,000 | -37.2% | 70,002 | -19.0% | 0.00% | – |
| Q1 2022 | $659,000 | +21866.7% | 86,427 | +7293.2% | 0.00% | – |
| Q3 2021 | $3,000 | -25.0% | 1,169 | +25.6% | 0.00% | – |
| Q2 2021 | $4,000 | +100.0% | 931 | +86.2% | 0.00% | – |
| Q1 2021 | $2,000 | -99.4% | 500 | -99.0% | 0.00% | – |
| Q4 2020 | $346,000 | -46.5% | 48,429 | -20.1% | 0.00% | – |
| Q3 2020 | $647,000 | -77.7% | 60,629 | -73.6% | 0.00% | – |
| Q2 2020 | $2,899,000 | +37.9% | 229,729 | 0.0% | 0.00% | – |
| Q1 2020 | $2,102,000 | -34.4% | 229,729 | 0.0% | 0.00% | – |
| Q4 2019 | $3,205,000 | -52.6% | 229,729 | -41.6% | 0.00% | -100.0% |
| Q3 2019 | $6,766,000 | -53.3% | 393,129 | -26.1% | 0.00% | -50.0% |
| Q2 2019 | $14,485,000 | +2.6% | 532,129 | -27.9% | 0.00% | 0.0% |
| Q1 2019 | $14,117,000 | +64.8% | 737,562 | -19.0% | 0.00% | +100.0% |
| Q4 2018 | $8,564,000 | -67.2% | 911,062 | -34.0% | 0.00% | -66.7% |
| Q3 2018 | $26,105,000 | -42.7% | 1,379,762 | -40.8% | 0.00% | -40.0% |
| Q2 2018 | $45,572,000 | -15.6% | 2,332,221 | -18.9% | 0.01% | -16.7% |
| Q1 2018 | $54,002,000 | -1.0% | 2,873,992 | -12.6% | 0.01% | 0.0% |
| Q4 2017 | $54,565,000 | -28.3% | 3,287,051 | -11.1% | 0.01% | -33.3% |
| Q3 2017 | $76,143,000 | +125.9% | 3,698,051 | -1.7% | 0.01% | +125.0% |
| Q2 2017 | $33,708,000 | -32.3% | 3,762,051 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $49,810,000 | -1.6% | 3,762,051 | -5.3% | 0.01% | -14.3% |
| Q4 2016 | $50,627,000 | +6.1% | 3,973,851 | 0.0% | 0.01% | +16.7% |
| Q3 2016 | $47,726,000 | +9.3% | 3,973,851 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $43,673,000 | +28.2% | 3,973,851 | +1.8% | 0.01% | +20.0% |
| Q1 2016 | $34,067,000 | -60.1% | 3,902,348 | 0.0% | 0.01% | -54.5% |
| Q4 2015 | $85,462,000 | – | 3,902,348 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |